You are here:- Finalised Projects .. HIDES .. HIDES 2

HIDES 2

 


HIDES 2 (HIV Indicator Diseases Across Europe Study) 
2011-2015

The HIDES study aims at developing focused HIV testing in patients presenting with certain clinical conditions and/or diseases.

Study aims:

1. Implement surveys to assess HIV prevalence for one or more diseases and/or conditions within a specific segment of the population not yet diagnosed with HIV and that present for care with the specific disease/condition.

  1. Presenting for care of malignant lymphoma, irrespective of type - patient information leaflet template
  2. Presenting for care of cervical or anal dysplasia or cancer, (Cervical CIN II and above) - patient information leaflet template CC - patient information leaflet template AC
  3. Presenting for care of Hepatitis B or C virus infection (acute or chronic – and irrespective of time of diagnosis relative to time of survey),
  4. Presenting with ongoing mononucleosis-like illness -patient information leaflet template
  5. Presenting with unexplained leukocytopenia or thrombocytopenia lasting at least 4 weeks -patient information leaflet template 
    Procedures for capturing data for ongoing mononucleosis-like illness from the laboratory
  6. Presenting with seborrheic dermatitis / exanthema -patient information leaflet template
  7. Presenting with pneumonia,  admitted to hospital for at least 24h  - patient information leaflet template
  8. Presenting with unexplained lymphadenopathy - patient information leaflet template
  9. Presenting with peripheral neuropathy of unknown cause (diagnosed by neurologist) - patient information leaflet template
  10. Presenting with primary lung cancer - patient information leaflet template
  11. Presenting with severe or recalcitrant psoriasis (newly diagnosed) - patient information leaflet template

2. Launch, implement and evaluate an audit system of the performance of HIV testing of persons presenting with a condition which has already been established as an indicator for HIV testing.

  1. Tuberculosis
  2. Non-hodgkin’s lymphoma
  3. Anal cancer
  4. Cervical cancer
  5. Hep B and C
  6. Candida esophagitis

HIDES2 presentation: 14th European Aids Conference, Friday 18th October 2013 in Brussels

Questionnaire - all participating centres

How to get involved  

Call for Collaboration

Newsletter - September 2012

Newsletter - March 2013

Newsletter - May 2013

Study documents
Protocol version 1.1, English
Protocol version 1.1, German
Protocol version 1.1, French
Protocol version 1.1, Spanish
Protocol version 1.1, Portuguese
Protocol version 1.1, Dutch
Protocol version 1.1, Russian

Instructions for auditing of HIV testing, English
Instructions for auditing of HIV testing, German
Instructions for auditing of HIV testing, French
Instructions for auditing of HIV testing, Spanish
Instructions for auditing of HIV testing, Portuguese
Instructions for auditing of HIV testing, Dutch
Instructions for auditing of HIV testing, Russian

HepHIV2014 Conference, Barcelona 5-7 October
HIDES Press release, 6 October 2014

English version
Russian version
NEWS
 Late presentation of chronic viral hepatitis for medical care: a consensus definition
Monday, May 08, 2017

New publication! Late presentation of chronic viral hepatitis for medical care: a consensus definition. Read the full article here.

 
 Two-day short course on Introduction to Cost-effectiveness Analysis for Infectious Diseases at UCL
Tuesday, April 04, 2017

Don't miss out! Join a two-day short course on Introduction to Cost-effectiveness Analysis for Infectious Diseases at UCL. The course takes place on 28 and 29 September 2017. Read more here.

 
 Evaluation of the HepHIV 2017 Conference
Monday, April 03, 2017

The evaluation report from the HepHIV conference is now available. You can access it here.

 
 The HIV in Europe 2016 Annual Report is now available!
Monday, April 03, 2017

You can now read about our 2016 projects, activities and achievements in our annual report. Find it here.

 
 New report: The HIV in Europe initiative - the first 10 years
Tuesday, January 31, 2017

2017 marks 10 years of HIV in Europe - read about the 10 years of working with different stakeholders to promote earlier testing and care in our new report

 
 HepHIV 2017 Malta Conference
Tuesday, January 31, 2017

HepHIV 2017 Conference is now taking place in Malta (31 January - 2 February 2017). See full programme here. You can also follow news and updates on Twitter by following the conference hashtag #HepHIV2017

 

Copyright 2009 by HIV in Europe
PLay slots online https://slotsdad.com/. Live dealer casinos https://livecasino.money/.